Prudential Financial Inc Oncternal Therapeutics, Inc. Transaction History

Prudential Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.56 $19,880 - $44,304	28,400 New	28,400 $32,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $4.39 $174,099 - $336,695	-76,696 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.37 - $4.76 $258,465 - $365,072	76,696 New	76,696 $320,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.